Cell Reports (Jan 2023)

SLC7A14 imports GABA to lysosomes and impairs hepatic insulin sensitivity via inhibiting mTORC2

  • Xiaoxue Jiang,
  • Kan Liu,
  • Haizhou Jiang,
  • Hanrui Yin,
  • En-duo Wang,
  • Hong Cheng,
  • Feixiang Yuan,
  • Fei Xiao,
  • Fenfen Wang,
  • Wei Lu,
  • Bo Peng,
  • Yousheng Shu,
  • Xiaoying Li,
  • Shanghai Chen,
  • Feifan Guo

Journal volume & issue
Vol. 42, no. 1
p. 111984

Abstract

Read online

Summary: Lysosomal amino acid accumulation is implicated in several diseases, but its role in insulin resistance, the central mechanism to type 2 diabetes and many metabolic diseases, is unclear. In this study, we show the hepatic expression of lysosomal membrane protein solute carrier family 7 member 14 (SLC7A14) is increased in insulin-resistant mice. The promoting effect of SLC7A14 on insulin resistance is demonstrated by loss- and gain-of-function experiments. SLC7A14 is further demonstrated as a transporter resulting in the accumulation of lysosomal γ-aminobutyric acid (GABA), which induces insulin resistance via inhibiting mTOR complex 2 (mTORC2)’s activity. These results establish a causal link between lysosomal amino acids and insulin resistance and suggest that SLC7A14 inhibition may provide a therapeutic strategy in treating insulin resistance-related and GABA-related diseases and may provide insights into the upstream mechanisms for mTORC2, the master regulator in many important processes.

Keywords